The STING pathway and the T cell-inflamed tumor microenvironment

Trends in Immunology
Seng-Ryong WooThomas F Gajewski

Abstract

A major subset of patients with advanced solid tumors show a spontaneous T cell-inflamed tumor microenvironment, which has prognostic import and is associated with clinical response to immunotherapies. As such, understanding the mechanisms governing the generation of spontaneous T cell responses in only a subset of patients is critical for advancing immunotherapeutic approaches further. Here, we discuss the characteristics of T cell-inflamed versus non-inflamed tumors, including a type I interferon (IFN) signature associated with T cell priming against tumor antigens. We review recent findings that have pointed towards the STING (stimulator of interferon genes) pathway of cytosolic DNA sensing as an important innate immune sensing mechanism driving type I IFN production in the tumor context. Knowledge of this pathway is guiding the further development of novel immunotherapeutic strategies.

References

Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy C PetersonThomas F Gajewski
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Steven A Rosenberg, Mark E Dudley
Sep 30, 2004·Nature Immunology·Akiko Iwasaki, Ruslan Medzhitov
Jun 14, 2005·Nature Immunology·Gavin P DunnRobert D Schreiber
Dec 24, 2005·The New England Journal of Medicine·Franck PagèsJérôme Galon
Feb 10, 2006·Cancer Immunology, Immunotherapy : CII·Helena HarlinThomas F Gajewski
Sep 16, 2006·Immunological Reviews·Thomas F GajewskiHelena Harlin
Feb 13, 2007·Current Opinion in Immunology·Jack D Bui, Robert D Schreiber
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas F Gajewski
Aug 1, 1997·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·B C Baguley, L M Ching
Mar 19, 2009·Cancer Research·Helena HarlinThomas F Gajewski
Sep 15, 2010·The Journal of Experimental Medicine·Giorgio Trinchieri
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernhard MlecnikJérôme Galon
Mar 26, 2011·The Journal of Clinical Investigation·Stephanie K WatkinsArthur A Hurwitz
Apr 12, 2011·Breast Cancer Research and Treatment·Maria Libera AsciertoMasoud H Manjili
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sahar M A MahmoudAndrew R Green
Jun 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Primo N LaraGiorgio Scagliotti
Sep 21, 2011·The Journal of Experimental Medicine·Mercedes B FuertesThomas F Gajewski
Sep 21, 2011·The Journal of Experimental Medicine·Mark S DiamondRobert D Schreiber
Feb 2, 2012·The Journal of Clinical Investigation·Hélène SalmonEmmanuel Donnadieu
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 20, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farhad AzimiJohn F Thompson
Nov 6, 2012·Trends in Immunology·Mercedes B FuertesThomas F Gajewski
Nov 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jeonghyun AhnGlen N Barber
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Apr 18, 2013·Cancer Research·Sylvie RusakiewiczLaurence Zitvogel
May 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fernando Ulloa-MontoyaVincent G Brichard
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nienke van RooijTon N Schumacher
Dec 5, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F BertucciS J Van Laere
Jan 21, 2014·Pigment Cell & Melanoma Research·Antoine BertolottiJulien Seneschal

❮ Previous
Next ❯

Citations

Jun 23, 2015·Expert Review of Anticancer Therapy·Charles PottierPascale Quatresooz
Feb 4, 2016·Trends in Immunology·David H Munn, Andrew L Mellor
Mar 22, 2016·Seminars in Immunology·Reno DebetsGeorge Coukos
Nov 26, 2015·Nature Reviews. Immunology·Glen N Barber
Jun 8, 2015·Cancer Immunology, Immunotherapy : CII·Manisha Singh, Willem W Overwijk
May 7, 2016·Science·Michael Bustin, Tom Misteli
Mar 2, 2016·Annual Review of Immunology·Susanne H BaumeisterArlene H Sharpe
May 22, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M Kim, D S Chen
Sep 14, 2016·Oncoimmunology·Erik LadomerskyDerek A Wainwright
Aug 25, 2016·Oral Oncology·Yu LeiGregory T Wolf
Sep 11, 2016·Mechanisms of Ageing and Development·Stephan GasserFlorence S G Cheung
Apr 29, 2016·BJU International·Jennifer M Mataraza, Philip Gotwals
Jan 13, 2018·Journal of Cellular Biochemistry·Shishir UpadhyayMonisha Dhiman
Nov 22, 2017·International Journal of Molecular Sciences·Debojit Bose
Sep 25, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Run FangZhengfan Jiang
Nov 7, 2017·Nature Structural & Molecular Biology·Yi-An ChenLiuh-Yow Chen
Feb 9, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anna Maria WirsingElin Hadler-Olsen
Jul 6, 2018·Natural Products and Bioprospecting·Hui-Fang Zhu, Yan Li
Sep 18, 2018·Expert Opinion on Biological Therapy·Priscilla de GraaffReno Debets
May 1, 2019·Journal for Immunotherapy of Cancer·Weiqing JingMichael B Dwinell
Dec 25, 2019·The Journal of Clinical Investigation·Xiaobo LuoYu L Lei
Feb 1, 2017·Advanced Biosystems·Sandeep T KoshyDavid J Mooney
Nov 5, 2019·Molecular Cancer·Yuanyuan ZhuXiaobo Li
May 22, 2020·Frontiers in Cell and Developmental Biology·Xing HuangTingbo Liang
Dec 23, 2016·Frontiers in Oncology·Valérie DutoitPaul R Walker
Jun 10, 2017·Journal of Inflammation·Yang LiEndre Kiss-Toth
Oct 24, 2019·Current Topics in Medicinal Chemistry·Yiqian LianJingsong Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

© 2022 Meta ULC. All rights reserved